Nishimura et al. [12] disclosed that from analysis of 88 patients with Dukes B/C CRC who received 5’-DFUR therapy, those with high tumor TP protein expression in enzyme-linked immunosorbent assay (ELISA) showed better prognosis. This evidence concerns the gene TYMP and neoplasm.